Caribou Biosciences
Price & Volume
Stats
See more52W Range | $0.66-$4.21 |
Market Cap | $68.3M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $9.9M |
Revenue Growth (YoY) | -41.6% |
Gross Profit (12 Mos) | -$119.5M |
Diluted EPS | -$1.65 |
News
See moreYahoo Finance • last month
Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance • 2 months ago
CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
About
CEO | Dr. Rachel E. Haurwitz Ph.D. |
Address | 2929 7th Street, Berkeley, CA, United States, 94710 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 147 |
